Smooth Drug Development September 2023 News Release

We are working on the following new projects:

• We signed a contract for medical writing activities for a BE trial with our long-term Client.

We are happy to reach the following milestones in our projects:

• We continue enrolling patients in Russia and India into an international phase III clinical trial of an original drug for patients with chronic myeloid leukemia. 79 subjects were enrolled in India.
• We prepared CTA submission documents for Liraglutide trial. This is a phase I trial.
• Clinical part was started in a BE trial with Vildagliptin.
• 3 patients were randomized in a phase III clinical trial in paroxysmal nocturnal hemoglobinuria.
• Clinical part is finished in BE trials with Empagliflozin, 10 mg and 25 mg.
• 1022 subjects are enrolled in an observational program of multivitamins in pregnant and childbearing women.